68216-65-9

Basic information

• Product Name: Benzaldehyde, 3-bromo-2,5-dimethoxy-
• CAS NO: 68216-65-9
• Molecular Formula: C9H9BrO3
• Molecular Weight: 245.073
• Mol File: 68216-65-9.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: Benzaldehyde, 3-bromo-2,5-dimethoxy-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzaldehyde, 3-bromo-2,5-dimethoxy-(68216-65-9)
• EPA Substance Registry System: Benzaldehyde, 3-bromo-2,5-dimethoxy-(68216-65-9)

Safety Data

• Hazardous Substances Data: 68216-65-9(Hazardous Substances Data)

Upstream product

• 50343-02-7 3-Bromo-2-hydroxy-5-methoxy-benzaldehyde 
• 80-48-8 methyl p-toluene sulfonate 
• 77-78-1 dimethyl sulfate 
• 672-13-9 2-hydroxy-5-methoxybenzaldehyde 
• 74-88-4 methyl iodide 

Downstream Products

• 100940-12-3 2,5-dimethoxy-3-bromobenzoic acid 
• 196302-51-9 (3-Bromo-2,5-dimethoxy-phenyl)-methanol 

Relevant articles and documents

Synthesis and Evaluation of Novel 7- and 8-Aminophenoxazinones for the Detection of β-Alanine Aminopeptidase Activity and the Reliable Identification of Pseudomonas aeruginosa in Clinical Samples

A series of novel 8-aminophenoxazin-3-one and 7-aminophenoxazin-3-one chromogens and their corresponding β-alanine derivatives were synthesized and evaluated for their ability to detect β-alanyl aminopeptidase activity in bacteria known to hydrolyze β-ala

NOVEL ESTROGEN RECEPTOR LIGANDS

The invention provides a pharmaceutical composition comprising a compound of formula (I) or a pharmaceutically acceptable ester, amide, solvate or salt thereof, including a salt of such an ester or amide, and a solvate of such an ester, amide or salt: wherein R3 is selected from the group consisting of ORA; -CHO; -C(O)C1-4alkyl; -C(O)phenyl; -O-C(O)RA; and N(RB)2; R6 is selected from certain cyclic groups defined in the specification; and the remaining groups are defined in the specification; together with a pharmaceutically acceptable carrier. Most of the compounds are novel. The invention also provides the use of such compounds in the treatment or prophylaxis of a condition associated with a disease or disorder associated with estrogen receptor activity.

A Convergent Synthesis of the Macrocyclic Core of Cytotrienins: Application of RCM for Macrocyclization

(Equation presented) The asymmetric synthesis of the fully elaborated macrocyclic core of cytotrienins A-D, potent apoptosis-inducing agents, is described. Synthetic highlights include the construction of the aniline bond using a copper-mediated amidation and the use of a ring-closing metathesis (RCM) reaction to efficiently install the (E,E,E)-triene and simultaneously construct the macrocyclic lactam.